Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
European Urology|March 6, 2007
Collecting duct renal cell carcinoma: a matched analysis of 41 casesPierre I Karakiewicz, Quoc-Dien Trinh, Nathalie Rioux-Leclercq, et al.
The Journal of Urology|October 20, 2009
Conditional survival predictions after nephrectomy for renal cell carcinomaPierre I Karakiewicz, Nazareno Suardi, Umberto Capitanio, et al.
BJU International|August 30, 2008
Prognostic variables to predict cancer-related death in incidental renal tumoursKarim Bensalah, Allan J Pantuck, Maxime Crepel, et al.
The New England Journal of Medicine|June 5, 2018
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell CarcinomaArnaud Méjean, Alain Ravaud, Simon Thezenas, et al.
Urologic Oncology|June 20, 2015
Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic featuresRomain Mathieu, Géraldine Pignot, Alexandre Ingles, et al.
BJU International|September 8, 2007
Unclassified renal cell carcinoma: an analysis of 85 casesPierre I Karakiewicz, Georg C Hutterer, Quoc-Dien Trinh, et al.
World Journal of Urology|March 15, 2023
Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approachMichael Baboudjian, Alberto Breda, Thierry Roumeguère, et al.
Basic and Clinical Andrology|December 11, 2023
Efficient pathway for men fertility preservation in testicular cancer or lymphoma: a cross-sectional study of national 2018 dataSégolène Prades, Sarah-Lyne Jos, Jacqueline Saïas-Magnan, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2019
Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international databaseNicolas Delanoy, Anne-Claire Hardy-Bessard, Eleni Efstathiou, et al.
Cell Reports. Medicine|October 19, 2022
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variantOlivier Demaria, Laurent Gauthier, Marie Vetizou, et al.
Pageof 12